Fernández-Barrés S., Perez G., Piñero M., Reyes A., Pérez K., Artazcoz L., Borrell C.. Effect of COVID-19 prevention as part of an urban renewal programme. PUBLIC HEALTH. 2023; 223DOI:10.1016/j.puhe.2023.07.014. PMID:37666182. IF:3.900(Q1/2D).

Pujade-Lauraine E, Brown J, Barnicle A, Wessen J, Lao-Sirieix P, Criscione SW, du Bois A, Lorusso D, Romero I, Petru E, Yoshida H, Vergote I, Colombo N, Hietanen S, Provansal M, Schmalfeldt B, Pignata S, Martín Lorente C, Berton D, Runnebaum IB, Ray-Coquard I. Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.. JCO Precision Oncology. 2023; 7DOI:10.1200/PO.22.00258. PMID:36716415. IF:5.300(Q1/2D).

Bonfill Cosp X.. Basic concepts for understanding and improving clinical appropriateness. Educacion Medica. 2023; 24(3)DOI:10.1016/j.edumed.2023.100813. PMID:. IF:(Q/D).

Lührsen D.S., Zavitsanou E., Cerecedo-Iglesias C., Pardo-Araujo M., Palmer J.R.B., Bartumeus F., Montalvo T., Michaelakis A., Lowe R.. Adult Aedes albopictus in winter: implications for mosquito surveillance in southern Europe. Lancet Planetary Health. 2023; 7(9)DOI:10.1016/S2542-5196(23)00170-5. PMID:37673540. IF:24.200(Q1/1D).

Pérez G., Bartroli M., Pasarín M.I., Artazcoz L., Juárez O.. Strategy for the promotion of equitable and healthy relationships in educational centers in Barcelona. Gaceta Sanitaria. 2023; 37DOI:10.1016/j.gaceta.2022.102286. PMID:36645958. IF:1.500(Q3/7D).

Günther G., Guglielmetti L., Leu C., Lange C., van Leth F., Hasan Hafizi, Khachatryan N., Aroyan H., Kabasakalyan E., Knappik M., Skrahina A., Klimuk D., Nikolenka A., Muylle I., Milanov V., Velkovska D., Tarinska N., Bachiyska E., Jankovic M., Pieridou D., Adamide T., Nicolaou N., Vasakova M., Sukholytka M., Kopeckà E., Folkvardsen D.B., Svensson E., Danilovits M., Kummik T., Vasankari T., Fréchet-Jachym M., Nahmiash A., Togonidze T., Avaliani Z., Kinkladze I., Aspindzelashvili R., Bichashvili T., Losaberidze G., Merabishvili T., Kalsdorf B., Manika K., Tsiakitzis K., Bakos A., Ægisdóttir T.R., Michelsen G.S., Karlsdóttir K., McLaughlin A.-M., Fitzgibbon M., Chemtob D., Codecasa L.R., Ferrarese M., Torri S., Gjocaj M., Kuksa L., Davidaviciene E., Wirtz G., Perrin M., Asciak A.P., Chesov D., de Lange W., Akkerman O., Poposka B.I., Mack U., Jensenius M., Kvalvik L., Mengshoel A.T., Kruczak K., Duarte R., Ribeiro N., Ibraim E., Kaluzhenina A., Barkanova O., Pesut D., Solovic I., Svetina P., Souza-Galvão M.-L.D., Millet J.-P., Casas X., Vives M., Bruchfeld J., Dalemo P., Jonsson J., Aeschbacher K., Keller P., Özkara S., Tiberi S., Chen C., Terleeva Y., Dudnyk A.. Availability and costs of medicines for the treatment of tuberculosis in Europe. CLINICAL MICROBIOLOGY AND INFECTION. 2023; 29(1)DOI:10.1016/j.cmi.2022.07.026. PMID:35961488. IF:10.900(Q1/1D).